TRV
LRMR icon

Third Rock Ventures’s Larimar Therapeutics LRMR Stock Holding History

Third Rock Ventures’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$6.72M Sell
17,531
-249,306
-93% -$112M 0.63% 5
2015
Q2 		$111M Sell
266,837
-83,333
-24% -$34.9M 11.54% 3
2015
Q1 		$166M Sell
350,170
-116,667
-25% -$55.4M 17.75% 3
2014
Q4 		$173M Hold
466,837
– – 14.13% 3
2014
Q3 		$110M Buy
+466,837
New +$106M 12.84% 3

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Third Rock Ventures's LRMR Position: Q3 2015 in Review

Third Rock Ventures reduced its Larimar Therapeutics (LRMR) stake by 93% in Q3 2015, selling an estimated $112M and leaving 17,531 shares worth $6.72M. The position accounts for 0.63% of the portfolio, ranked #5.

Third Rock Ventures first reported a position in LRMR in Q3 2014 and has held it in 5 quarters since. The position peaked at $173M in Q4 2014. 96 funds tracked by Wall St. Rank hold LRMR as of Q3 2015.

  • Third Rock Ventures held 17,531 shares of Larimar Therapeutics worth $6.72M as of Q3 2015.
  • Third Rock Ventures sold 249,306 Larimar Therapeutics shares in Q3 2015, an estimated $112M.
  • Larimar Therapeutics made up 0.63% of Third Rock Ventures's portfolio in Q3 2015, its #5 holding.
  • Third Rock Ventures first reported a position in Larimar Therapeutics in Q3 2014 and has held it in 5 quarters since.
  • Third Rock Ventures's Larimar Therapeutics position peaked at $173M in Q4 2014.
  • 96 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2015.

Based on Third Rock Ventures's 13F filing for Q3 2015, filed 3 Nov 2015.